Patent · US Active

Compounds to inhibit calcium/calmodulin dependent protein kinase II and applications thereof

US10494334B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

ACADEMIA SINICA · TW

Inventors

Wen-Shan Li · Taipei, TW
Yi-Ling Lin · Taipei, TW
Wei Chen · Acton, US
Yogy Simanjuntak · Yogyakarta, ID

Key dates

Filing date	Mar 20, 2019
Grant date	Dec 3, 2019
Priority date	—
Expiry date	Mar 20, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are novel benzenesulfonamide compounds that inhibit calcium/calmodulin-dependent protein kinase II (CaMKII) and pharmaceutical compositions containing the benzenesulfonamide compounds. Also provided are methods of using the benzenesulfonamide compounds to treat diseases or conditions that are associated with CaMKII activity, such as a flavivirus infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.